Co-led Cyclana Bio's £5M pre-seed for endometriosis drug discovery using menstrual fluid biomarker analysis.
Added recently
Cyclana Bio is focused on developing treatments for endometriosis by harnessing tissue and matrix biology
Cyclana Bio is focused on developing treatments for endometriosis by harnessing tissue and matrix biology. The company aims to uncover mechanisms in women's health and create better treatment options through innovative research and collaboration.